Drugs, regulation in horse racing discussed on Capitol Hill
Posted Dec. 18, 2013
Once again, Congress is eyeing implementing reforms in North American horse racing, but, this time, it’s looking to an outside organization to achieve changes.
A hearing was held Nov. 21, 2013, before the House Subcommittee on Commerce, Manufacturing, and Trade regarding the Horseracing Integrity and Safety Act of 2013 (S. 973/H.R. 2012), which would impose new restrictions on medication use in racehorses.
In May 2013, New Mexico Sen. Tom Udall and Pennsylvania Rep. Joe Pitts introduced the legislation. If enacted, it would designate the U.S. Anti-Doping Agency as the national and independent nongovernmental organization that would develop, maintain, and publish rules on medications used in racehorses. The rules would cover areas of drug withdrawal periods, approved treatments in the context of a veterinarian-client-patient-relationship, and prohibited substances and treatments.
Under the legislation, the USADA would also be charged with implementing programs relating to anti-doping education, research, testing, and adjudication to prevent any horse from participating in a race while under the effects of any substance or treatment that could affect its performance.
continue to read here
No comments:
Post a Comment